| # | Title | Journal | Year | Citations |
|---|
| 1 | Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic | Applied Biosafety | 2020 | 137 |
| 2 | Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges | Applied Biosafety | 2020 | 89 |
| 3 | Comparison of Multiple Systems for Laboratory Whole Room Fumigation | Applied Biosafety | 2011 | 53 |
| 4 | Monitoring Select Agent Theft, Loss and Release Reports in the United States—2004–2010 | Applied Biosafety | 2012 | 47 |
| 5 | Area Fumigation with Hydrogen Peroxide Vapor | Applied Biosafety | 2005 | 46 |
| 6 | The Infectious Dose ofFrancisella Tularensis(Tularemia) | Applied Biosafety | 2005 | 45 |
| 7 | The Infectious Dose ofCoxiella Burnetii(Q Fever) | Applied Biosafety | 2006 | 41 |
| 8 | Does That Face Mask Really Protect You? | Applied Biosafety | 2010 | 41 |
| 9 | Contained use of Bacteriophages: Risk Assessment and Biosafety Recommendations | Applied Biosafety | 2010 | 41 |
| 10 | Use of Ultraviolet Lights in Biological Safety Cabinets: A Contrarian View | Applied Biosafety | 2006 | 36 |
| 11 | Staphylococcal Enterotoxin B as a Biological Weapon: Recognition, Management, and Surveillance of Staphylococcal Enterotoxin | Applied Biosafety | 2006 | 36 |
| 12 | High-Dose Ultraviolet C Light Inactivates Spores ofBacillus AtrophaeusandBacillus AnthracisSterne on Nonreflective Surfaces | Applied Biosafety | 2005 | 30 |
| 13 | Evaluation of SARS-Coronavirus Decontamination Procedures | Applied Biosafety | 2007 | 29 |
| 14 | Crisis and Emergency Risk Communication | Applied Biosafety | 2005 | 28 |
| 15 | Unreliable Inactivation of Viruses by Commonly Used Lysis Buffers | Applied Biosafety | 2017 | 28 |
| 16 | The Infectious Dose of Variola (Smallpox) Virus | Applied Biosafety | 2004 | 27 |
| 17 | Evaluation of a Dry Fogging System for Laboratory Decontamination | Applied Biosafety | 2012 | 24 |
| 18 | Adaptive Risk Management of Gene Drive Experiments | Applied Biosafety | 2017 | 24 |
| 19 | The Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences: A Comprehensive Literature Review | Applied Biosafety | 2019 | 24 |
| 20 | In Vitro Inactivation of SARS-CoV-2 Using Gamma Radiation | Applied Biosafety | 2020 | 24 |
| 21 | Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators | Applied Biosafety | 2020 | 24 |
| 22 | Issues Affecting Respirator Selection for Workers Exposed to Infectious Aerosols: Emphasis on Healthcare Settings | Applied Biosafety | 2004 | 23 |
| 23 | Neutralization of Formaldehyde Gas by Ammonium Bicarbonate and Ammonium Carbonate | Applied Biosafety | 2005 | 23 |
| 24 | Innovations—Biotechnology: Baculovirus Vectors as Gene Transfer Vectors for Mammalian Cells: Biosafety Considerations | Applied Biosafety | 2002 | 22 |
| 25 | Vaporized Hydrogen Peroxide-Based Biodecontamination of a High-Containment Laboratory under Negative Pressure | Applied Biosafety | 2006 | 22 |
| 26 | Biosafety Training and Incident-Reporting Practices in the United States: A 2008 Survey of Biosafety Professionals | Applied Biosafety | 2009 | 22 |
| 27 | Position Paper on the Use of Ultraviolet Lights in Biological Safety Cabinets | Applied Biosafety | 2006 | 19 |
| 28 | Chlorine Dioxide Gas Decontamination of Large Animal Hospital Intensive and Neonatal Care Units | Applied Biosafety | 2006 | 19 |
| 29 | Implications of Low Level Human Exposure to Respirable B. Anthracis | Applied Biosafety | 2007 | 19 |
| 30 | Human Health and Environmental Risks Posed by Synthetic Biology R&D for Energy Applications | Applied Biosafety | 2016 | 19 |
| 31 | Inactivation ofFrancisella tularensisSchu S4 in a Biological Safety Cabinet Using Hydrogen Peroxide Fumigation | Applied Biosafety | 2008 | 18 |
| 32 | Approaches to Reduce CRISPR Off-Target Effects for Safer Genome Editing | Applied Biosafety | 2017 | 18 |
| 33 | Validation Study for the Use of Chlorine Dioxide Gas as a Decontaminant for Biological Safety Cabinets | Applied Biosafety | 2008 | 17 |
| 34 | Virucidal Activity of Disinfectants against Parvoviruses and Reference Viruses | Applied Biosafety | 2010 | 17 |
| 35 | International Biosafety and Biosecurity Challenges: Suggestions for Developing Sustainable Capacity in Low-resource Countries | Applied Biosafety | 2011 | 17 |
| 36 | Evaluation of TRIzol LS Inactivation of Viruses | Applied Biosafety | 2017 | 17 |
| 37 | Developing a Comprehensive, Adaptive, and International Biosafety and Biosecurity Program for Advanced Biotechnology: The iGEM Experience | Applied Biosafety | 2019 | 17 |
| 38 | OSHA Infectious Dose White Paper | Applied Biosafety | 2003 | 16 |
| 39 | Gaseous Decontamination Methods in High-containment Laboratories | Applied Biosafety | 2012 | 16 |
| 40 | Animal Cell Cultures: Risk Assessment and Biosafety Recommendations | Applied Biosafety | 2007 | 15 |
| 41 | Practices and Awareness regarding Biosafety Measures among Laboratory Technicians Working in Clinical Laboratories in Karachi, Pakistan | Applied Biosafety | 2010 | 15 |
| 42 | How to Choose a Suit for a BSL-4 Laboratory—The Approach Taken at SPIEZ LABORATORY | Applied Biosafety | 2011 | 15 |
| 43 | Survival of Microorganisms on HEPA Filters | Applied Biosafety | 2011 | 15 |
| 44 | Microbes in Irrigation Water and Fresh Vegetables | Applied Biosafety | 2016 | 15 |
| 45 | Plasma-Activated Aerosolized Hydrogen Peroxide (aHP) in Surface Inactivation Procedures | Applied Biosafety | 2019 | 14 |
| 46 | Bacillus AnthracisSpore Inactivation by Fumigant Decontamination | Applied Biosafety | 2008 | 13 |
| 47 | Large-Scale Inactivation ofBacillus AnthracisAmes, Vollum, and Sterne Spores Using Vaporous Hydrogen Peroxide | Applied Biosafety | 2009 | 13 |
| 48 | A Discussion of Biological Safety Cabinet Decontamination Methods: Formaldehyde, Chlorine Dioxide, and Vapor Phase Hydrogen Peroxide | Applied Biosafety | 2011 | 13 |
| 49 | Experience with Ribavirin for Treatment and Postexposure Prophylaxis of Hemorrhagic Fever Viruses: Crimean Congo Hemorrhagic Fever, Lassa Fever, and Hantaviruses | Applied Biosafety | 2011 | 12 |
| 50 | A Searchable Laboratory-Acquired Infection Database | Applied Biosafety | 2016 | 12 |
